(Q37984817)

26 August 2017

Pivotal roles of the interleukin-23/T helper 17 cell axis in hepatitis B. (English)

1 reference

26 August 2017

0 references

Zemin Huang

1

1 reference

26 August 2017

Jennifer C van Velkinburgh

series ordinal

2

1 reference

26 August 2017

Bing Ni

series ordinal

3

1 reference

26 August 2017

Yuzhang Wu

series ordinal

4

1 reference

26 August 2017

19 February 2012

1 reference

26 August 2017

1 reference

26 August 2017

32

1 reference

26 August 2017

894-901

1 reference

26 August 2017

6

1 reference

Fibrosis in chronic viral hepatitis.

26 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Hepatitis B and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Intrahepatic T cells in hepatitis B: viral control versus liver cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Gene expression signatures of peripheral CD4+ T cells clearly discriminate between patients with acute and chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Regulatory T cells and viral liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Involvement of Th17 and Th1 effector responses in patients with Hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Regulation and pro-inflammatory function of interleukin-17 family cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Transforming growth factor-beta induces development of the T(H)17 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Interleukin-23: a key cytokine in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Implication of Th17 and Th1 cells in patients with chronic active hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Emergence of the Th17 pathway and its role in host defense.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Expression of interleukin-17RC protein in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

The interleukin-17 pathway is involved in human alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Interleukin-17 family and IL-17 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Cutting edge: interleukin 17 signals through a heteromeric receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

An overview of IL-17 function and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Activated IL-23/IL-17 pathway closely correlates with increased Foxp3 expression in livers of chronic hepatitis B patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

IL-22 increases the innate immunity of tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

IL-17 and IL-22: siblings, not twins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

The role of interleukin-22 in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

What kind of message does IL-12/IL-23 bring to macrophages and dendritic cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02764.X

10.1111/J.1478-3231.2012.02764.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference